Pembrolizumab in Patients With Leptomeningeal Disease
Clinical trial NCT03091478 · TERMINATED
Trial details
- NCT number
- NCT03091478
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-12
- Primary completion
- 2019-12-14
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.